A detailed history of Sara Bay Financial transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sara Bay Financial holds 9,884 shares of MRK stock, worth $1.01 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
9,884
Previous 9,508 3.95%
Holding current value
$1.01 Million
Previous $1.18 Billion 4.64%
% of portfolio
0.41%
Previous 0.48%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$111.15 - $128.97 $41,792 - $48,492
376 Added 3.95%
9,884 $1.12 Billion
Q2 2024

Jul 19, 2024

BUY
$123.8 - $132.96 $149,550 - $160,615
1,208 Added 14.55%
9,508 $1.18 Billion
Q1 2024

Apr 16, 2024

BUY
$113.24 - $131.95 $270,077 - $314,700
2,385 Added 40.32%
8,300 $1.09 Billion
Q3 2023

Oct 13, 2023

BUY
$102.95 - $114.33 $104,288 - $115,816
1,013 Added 20.67%
5,915 $609 Million
Q2 2023

Jul 14, 2023

BUY
$108.61 - $118.38 $13,684 - $14,915
126 Added 2.64%
4,902 $566 Million
Q4 2022

Jan 11, 2023

BUY
$87.44 - $112.11 $29,991 - $38,453
343 Added 7.74%
4,776 $530 Million
Q3 2022

Oct 18, 2022

BUY
$84.53 - $94.96 $40,574 - $45,580
480 Added 12.14%
4,433 $382 Million
Q2 2022

Jul 12, 2022

BUY
$83.49 - $94.64 $50,594 - $57,351
606 Added 18.11%
3,953 $364 Million
Q1 2021

Apr 14, 2021

SELL
$68.86 - $81.11 $6,059 - $7,137
-88 Reduced 2.56%
3,347 $258 Million
Q4 2020

Jan 15, 2021

SELL
$71.77 - $79.65 $7,177 - $7,965
-100 Reduced 2.83%
3,435 $281 Million
Q3 2020

Oct 07, 2020

BUY
$73.18 - $82.95 $36,736 - $41,640
502 Added 16.55%
3,535 $293 Million
Q2 2020

Jul 21, 2020

BUY
$70.42 - $80.13 $213,583 - $243,034
3,033 New
3,033 $238 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sara Bay Financial Portfolio

Follow Sara Bay Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sara Bay Financial, based on Form 13F filings with the SEC.

News

Stay updated on Sara Bay Financial with notifications on news.